Phillip L.R. Nicolson

1.1k total citations
32 papers, 368 citations indexed

About

Phillip L.R. Nicolson is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Phillip L.R. Nicolson has authored 32 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 9 papers in Genetics and 8 papers in Surgery. Recurrent topics in Phillip L.R. Nicolson's work include Platelet Disorders and Treatments (17 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Phillip L.R. Nicolson is often cited by papers focused on Platelet Disorders and Treatments (17 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Phillip L.R. Nicolson collaborates with scholars based in United Kingdom, France and Saudi Arabia. Phillip L.R. Nicolson's co-authors include Steve P. Watson, Mark R. Thomas, Christopher W. Smith, Vadim Markovtsov, Nichola Cooper, Samantha J. Montague, Waleed Ghanima, Quentin A. Hill, Craig M. Kessler and Alice Y. Pollitt and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Phillip L.R. Nicolson

27 papers receiving 367 citations

Peers

Phillip L.R. Nicolson
Angie Tuttle Canada
M. Bhavnani United Kingdom
Manuel Campos Portugal
Thomas Sailer Austria
Xiaoying Sun China
Brigitte Pan‐Petesch France
Marshall Mazepa United States
A. Franke Germany
Andrea Duminuco Italy
Tracy Wiczer United States
Angie Tuttle Canada
Phillip L.R. Nicolson
Citations per year, relative to Phillip L.R. Nicolson Phillip L.R. Nicolson (= 1×) peers Angie Tuttle

Countries citing papers authored by Phillip L.R. Nicolson

Since Specialization
Citations

This map shows the geographic impact of Phillip L.R. Nicolson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip L.R. Nicolson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip L.R. Nicolson more than expected).

Fields of papers citing papers by Phillip L.R. Nicolson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip L.R. Nicolson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip L.R. Nicolson. The network helps show where Phillip L.R. Nicolson may publish in the future.

Co-authorship network of co-authors of Phillip L.R. Nicolson

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip L.R. Nicolson. A scholar is included among the top collaborators of Phillip L.R. Nicolson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip L.R. Nicolson. Phillip L.R. Nicolson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fratter, Carl, Will Lester, Charles Percy, et al.. (2025). The diagnostic utility of genetic testing in inherited thrombocytopenia: regional multicenter tertiary experience. Research and Practice in Thrombosis and Haemostasis. 9(3). 102869–102869.
2.
3.
4.
5.
Buka, Richard J., Bryar Kadir, Andrew J. Doyle, et al.. (2024). Rapido: Results from a UK-Wide Audit of 2477 Patients Who Received a Reversal Agent for a Direct Oral Anticoagulant. Blood. 144(Supplement 1). 2637–2637.
6.
Gardner, Joshua, Simon T. Abrams, Cheng‐Hock Toh, et al.. (2024). Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines. npj Vaccines. 9(1). 99–99. 6 indexed citations
7.
Buka, Richard J., et al.. (2023). PF4 activates the c-Mpl–Jak2 pathway in platelets. Blood. 143(1). 64–69. 20 indexed citations
8.
Gomez, Keith, et al.. (2023). How will UK hospitals use andexanet alfa? A review of local protocols. SHILAP Revista de lepidopterología. 4(1). 298–300. 3 indexed citations
9.
Abrams, Simon T., Min Du, Rebecca Shaw, et al.. (2023). Damage-associated cellular markers in the clinical and pathogenic profile of vaccine-induced immune thrombotic thrombocytopenia. Journal of Thrombosis and Haemostasis. 22(4). 1145–1153. 7 indexed citations
10.
Kavanagh, Dean, Paul Harrison, Alexandre Slater, et al.. (2023). Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy. Journal of Thrombosis and Haemostasis. 21(11). 3236–3251. 11 indexed citations
11.
Kemble, Samuel, Amanda Dalby, Gillian Lowe, et al.. (2022). Analysis of preplatelets and their barbell platelet derivatives by imaging flow cytometry. Blood Advances. 6(9). 2932–2946. 12 indexed citations
12.
Smith, Christopher W., et al.. (2022). The Btk inhibitor AB‐95‐LH34 potently inhibits atherosclerotic plaque–induced thrombus formation and platelet procoagulant activity. Journal of Thrombosis and Haemostasis. 20(12). 2939–2952. 9 indexed citations
13.
Montague, Samantha J., Christopher W. Smith, Matthew B. Roberts, et al.. (2022). Anti‐platelet factor 4 immunoglobulin G levels in vaccine‐induced immune thrombocytopenia and thrombosis: Persistent positivity through 7 months. Research and Practice in Thrombosis and Haemostasis. 6(3). e12707–e12707. 11 indexed citations
14.
Chayouâ, Walid, Phillip L.R. Nicolson, Joost C.M. Meijers, et al.. (2021). Antiprothrombin antibodies induce platelet activation: A possible explanation for anti‐FXa therapy failure in patients with antiphospholipid syndrome?. Journal of Thrombosis and Haemostasis. 19(7). 1776–1782. 18 indexed citations
15.
Nicolson, Phillip L.R., Sarah Essex, Roderick Oakes, et al.. (2021). The clinical course of COVID‐19 in pregnant versus non‐pregnant women requiring hospitalisation: results from the multicentre UK CA‐COVID‐19 study. British Journal of Haematology. 195(1). 85–89. 7 indexed citations
16.
Khan, Abdullah O., Alexandre Slater, Phillip L.R. Nicolson, et al.. (2020). Post-translational polymodification of β1-tubulin regulates motor protein localization in platelet production and function. Haematologica. 107(1). 243–259. 15 indexed citations
17.
Nicolson, Phillip L.R., Christopher W. Smith, Joana Campos, et al.. (2020). Low-dose Btk inhibitors selectively block platelet activation by CLEC-2. Haematologica. 106(1). 208–219. 39 indexed citations
18.
Nicolson, Phillip L.R., Craig E. Hughes, Stephanie L. Watson, et al.. (2018). Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI. Haematologica. 103(12). 2097–2108. 54 indexed citations
19.
Nicolson, Phillip L.R., et al.. (2017). Mild bleeding disorders: what every clinician should know. British Journal of Hospital Medicine. 78(12). 684–710. 1 indexed citations
20.
Gajendragadkar, Parag, et al.. (2013). The survival time of chocolates on hospital wards: covert observational study. BMJ. 347(dec13 7). f7198–f7198. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angie Tuttle Breakdown of academic impact, for papers by M. Bhavnani Breakdown of academic impact, for papers by Manuel Campos Breakdown of academic impact, for papers by Thomas Sailer Breakdown of academic impact, for papers by Xiaoying Sun Breakdown of academic impact, for papers by Brigitte Pan‐Petesch Breakdown of academic impact, for papers by Marshall Mazepa Breakdown of academic impact, for papers by A. Franke Breakdown of academic impact, for papers by Andrea Duminuco Breakdown of academic impact, for papers by Tracy Wiczer
Rankless by CCL
2026